Targets

Therapy methods

anti-CD3/anti-CD133 bispecific antibodies + NK cells
Telomestatin + BIBR 1532
CP-31398 + p53 peptide-based vaccines
PRIMA-1 + p53 peptide-based vaccines
Irinotecan + Dofequidar fumarate
Liposomal Daunorubicin + Tamoxifen
Irinotecan + YHO-13351
Irinotecan + YHO-13177
Mitoxantrone + Vismodegib
Topotecan + Vismodegib
Vismodegib + SN38
Gemcitabine + Dimethylamino parthenolide
Mitomysin + Cyclopamine
Oxaliplatin + Cyclopamine
Carfilzomib + Vismodegib
Carfilzomib + Reversin 121
Trastuzumab + XL147
Trastuzumab emtansine
DZNeP + Gemcitabine
IM7-Saporin + PCI
Back to top